意大利、西班牙和土耳其的血红蛋白病移民和筛查计划。
Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey.
机构信息
Thalassemia Diagnosis Center of Mediterranean Blood Diseases Foundation, Antalya (Turkey).
Red Blood Cell and Haematopoietic Disorders Unit, Institute for Leukemia Research Josep Carreras (IJC) and University of Barcelona, Catalonia (Spain).
出版信息
Acta Biomed. 2021 Sep 2;92(4):e2021410. doi: 10.23750/abm.v92i4.11965.
Abstract
Sickle cell disease (SCD) and thalassemias are the most common monogenic diseases in the world. The number of migrants and refugees in Europe and Turkey, in the past decade, has increased dramatically due to war, violence or prosecutions in their homeland. Prevention and management of haemoglobin disorders is well established and managed in countries where these conditions were traditionally endemic or in countries that have a longstanding tradition of receiving migrants. Therefore, preventive and diagnostic programmes regarding hemoglobinopathies in immigrant populations have been implemented. The purpose of this paper it to report a summary of the experience gained in Italy, Spain and Turkey in migrants, asylum seekers and refugees.
摘要
镰状细胞病（SCD）和地中海贫血症是世界上最常见的单基因疾病。由于战争、暴力或在原籍国受到起诉，过去十年来，欧洲和土耳其的移民和难民人数急剧增加。在这些疾病传统流行的国家或在长期接收移民的国家，血红蛋白疾病的预防和管理已经得到很好的确立和管理。因此，已经针对移民人群中的血红蛋白病实施了预防和诊断计划。本文的目的是报告意大利、西班牙和土耳其在移民、寻求庇护者和难民方面所获得经验的总结。
相似文献
1
Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey.意大利、西班牙和土耳其的血红蛋白病移民和筛查计划。
Acta Biomed. 2021 Sep 2;92(4):e2021410. doi: 10.23750/abm.v92i4.11965.
2
Refugee movements and Turkey.难民流动与土耳其。
Int Migr. 1991 Dec;29(4):545-60. doi: 10.1111/j.1468-2435.1991.tb01039.x.
3
Immigration and changes in the epidemiology of hemoglobin disorders in Italy : an emerging public health burden.移民和意大利血红蛋白疾病流行病学的变化：一个新出现的公共卫生负担。
Ital J Pediatr. 2012 Jul 23;38:32. doi: 10.1186/1824-7288-38-32.
4
Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.预防地方性和非地方性移民国家严重血红蛋白病的策略：拉齐奥地区的实例。
Prenat Diagn. 2009 Dec;29(12):1171-4. doi: 10.1002/pd.2382.
5
Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".“不断变化的欧洲”中镰状细胞病及其他血红蛋白病的新生儿筛查
Clin Lab. 2014;60(12):2089-93. doi: 10.7754/clin.lab.2014.140701.
6
Different forms, reasons and motivations for return migration of persons who voluntarily decide to return to their countries of origin.自愿决定返回原籍国的人员回返移民的不同形式、原因和动机。
Int Migr. 1986 Mar;24(1):61-76. doi: 10.1111/j.1468-2435.1986.tb00102.x.
7
Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.土耳其尼代省婚前检查中血红蛋白病的流行情况。
Hemoglobin. 2023 Nov;47(2):36-41. doi: 10.1080/03630269.2023.2206971. Epub 2023 May 15.
8
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies.在西欧和土耳其重新安置的寻求庇护者和难民中精神障碍发展的风险因素：两项大型预防研究的参与者层面分析。
Int J Soc Psychiatry. 2023 May;69(3):664-674. doi: 10.1177/00207640221132430. Epub 2022 Nov 3.
9
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population].[加泰罗尼亚血红蛋白病和葡萄糖-6-磷酸脱氢酶的新生儿筛查。匿名无关人群的试点研究]
Med Clin (Barc). 2006 Mar 4;126(8):281-5. doi: 10.1157/13085481.
10
[The health of asylum seekers: from communicable disease screening to post-traumatic disorders].[寻求庇护者的健康：从传染病筛查到创伤后障碍]
Bull Soc Pathol Exot. 1997;90(4):233-7.
引用本文的文献
1
Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c.检验医学设备的准确性与有效性之间的关联：运用欧盟卫生技术评估（EUnetHTA）核心模型通过测量糖化血红蛋白（HbA1c）来比较两台分析仪。
Int J Technol Assess Health Care. 2024 Dec 3;40(1):e67. doi: 10.1017/S0266462324000497.
2
Perinatal outcome of immigrant women with and without refugee status compared to non-immigrant women: results of the pregnancy and obstetric care for refugees (PROREF) cross-sectional study.比较有难民身份和无难民身份的移民妇女与非移民妇女的围产期结局：难民妊娠和产科护理（PROREF）横断面研究结果。
Arch Gynecol Obstet. 2024 Nov;310(5):2413-2424. doi: 10.1007/s00404-024-07639-3. Epub 2024 Aug 16.
3
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in Italy.十年的新生儿血红蛋白病筛查计划在弗留利-威尼斯朱利亚地区：意大利的首次区域经验。
Blood Transfus. 2024 Nov;22(6):529-536. doi: 10.2450/BloodTransfus.646. Epub 2023 Nov 30.
4
The blood count as a compass to navigate in the ever-changing landscape of the carrier state of hemoglobinopathies: a single-center Italian experience.血细胞计数作为在血红蛋白病携带者状态不断变化的格局中导航的指南针：意大利单中心经验
Front Pediatr. 2023 Oct 6;11:1228443. doi: 10.3389/fped.2023.1228443. eCollection 2023.
5
The pivotal role of HbA1c assay to detect hemoglobinopathies: A 5-year observational retrospective study in the population of Southern France.糖化血红蛋白（HbA1c）检测在诊断血红蛋白病中的关键作用：法国南部人群的一项5年观察性回顾研究
Health Sci Rep. 2023 Jul 16;6(7):e1270. doi: 10.1002/hsr2.1270. eCollection 2023 Jul.
6
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.制定改善镰状细胞病结局的全球战略：柳叶刀血液学委员会。
Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11.
7
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.德国血红蛋白病的筛查和诊断：现状与未来展望。
Sci Rep. 2022 Jun 13;12(1):9762. doi: 10.1038/s41598-022-13751-8.
本文引用的文献
1
The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.《重新审视地中海贫血症的预防：地中海贫血国际联合会的历史和伦理视角》。
Hemoglobin. 2021 Jan;45(1):5-12. doi: 10.1080/03630269.2021.1872612. Epub 2021 Jan 18.
2
Newborn Screening for Sickle Cell Disease in Europe.欧洲镰状细胞病的新生儿筛查
Int J Neonatal Screen. 2019 Feb 12;5(1):15. doi: 10.3390/ijns5010015. eCollection 2019 Mar.
3
Update of the Spanish registry of haemoglobinopathies in children and adults.西班牙儿童和成人血红蛋白病登记处的更新情况。
Med Clin (Barc). 2020 Aug 14;155(3):95-103. doi: 10.1016/j.medcli.2019.10.011. Epub 2020 Feb 26.
4
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.当前镰状细胞病患者管理面临的挑战——意大利经验报告。
Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
5
Access to emergency departments for acute events and identification of sickle cell disease in refugees.难民急性事件的急诊科就诊情况及镰状细胞病的识别
Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11.
6
Refugee children with beta-thalassemia in Turkey: Overview of demographic, socioeconomic, and medical characteristics.土耳其患有β-地中海贫血症的难民儿童：人口统计学、社会经济学和医学特征概述。
Pediatr Blood Cancer. 2019 May;66(5):e27636. doi: 10.1002/pbc.27636. Epub 2019 Feb 1.
7
The current state of sickle cell trait: implications for reproductive and genetic counseling.镰状细胞特征的现状：对生殖和遗传咨询的影响。
Blood. 2018 Nov 29;132(22):2331-2338. doi: 10.1182/blood-2018-06-848705.
8
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.欧洲新生儿镰状细胞病筛查：泛欧共识会议的建议。
Br J Haematol. 2018 Nov;183(4):648-660. doi: 10.1111/bjh.15600. Epub 2018 Oct 18.
9
Universal Screening Program in Pregnant Women and Newborns at-Risk for Sickle Cell Disease: First Report from Northern Italy.针对镰状细胞病高危孕妇和新生儿的普遍筛查项目：来自意大利北部的首份报告。
Hemoglobin. 2017 Jul-Nov;41(4-6):230-233. doi: 10.1080/03630269.2017.1405820. Epub 2017 Dec 12.
10
European migration crises: The role of national hemoglobinopathy registries in improving patient access to care.欧洲移民危机：国家血红蛋白病登记处对改善患者医疗服务可及性的作用。
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26515. Epub 2017 Mar 30.
Zotero 插件